Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

HSAQ - Health Sciences Acquisitions Corp 2


Close
11.5
-0.250   -2.174%

Share volume: 0
Last Updated: Fri 27 Jan 2023 10:00:00 PM CET

PREVIOUS CLOSE
CHG
CHG%

$11.75
-0.25
-2.13%
This ticker is disabled and data are no longer maintained and up to date.
Performance
5 Days
32.83%
1 Month
33.50%
3 Months
33.30%
6 Months
32.83%
1 Year
34.85%
2 Year
7.95%
Key data
Stock price
$11.50
P/E Ratio 
0.00
DAY RANGE
$10.44 - N/A
EPS 
$0.00
52 WEEK RANGE
$9.41 - $13.80
52 WEEK CHANGE
$0.36
MARKET CAP 
149.233 M
YIELD 
N/A
SHARES OUTSTANDING 
11.212 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$299,813
AVERAGE 30 VOLUME 
$186,183
Company detail
CEO:
Region: US
Website:
Employees: 4
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Health Sciences Acquisitions Corporation 2 is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The sponsor of the Company is HSAC 2 Holdings, LLC, an affiliate of RTW Investments, LP. HSAC 2 anticipates targeting companies domiciled in North America or Europe that are developing assets in the biopharmaceutical and medical technology sectors, which aligns with the Company's management team's experience in healthcare investing and drug development.

Recent news